In this video, Anjay Rastogi, MD, PhD, professor and Clinical Chief of Nephrology at the David Geffen School of Medicine at UCLA, discusses treatment options for chronic kidney disease patients with ...

Colon cancer is one of the most common cancers in the world today, and is increasingly targeting even young people, under 45 ...

Iron deficiency is globally widespread. Women are particularly affected, with one in five in Europe suffering from iron ...

The Sickle Cell Disease Treatment Market offers significant opportunities with advancements in gene editing, stem cell therapies, and precision medicine driving innovation. Increased awareness and ...

In a world-first trial, scientists used a one-off CRISPR gene edit to switch off a liver “fat brake” gene, slashing stubborn ...

The combination of alnodesertib and irinotecan shows promising efficacy in ATM-negative metastatic colorectal cancer, with a ...

So I did what so many runners do and pushed myself to run through exhaustion. And when that became unsustainable, I shortened ...

Harout Semerjian, whose pedigree includes launching the Novartis cancer blockbuster Gleevec, is aiming to boost awareness about Geron’s Rytelo to give it momentum.

Japanese researchers found that lecanemab, an amyloid-clearing drug for Alzheimer’s, does not improve the brain’s waste clearance system in the short term. This implies that nerve damage and impaired ...

Researchers are reporting two promising approaches to counteract malaria's growing drug resistance. Switzerland-based ...

Iron deficiency is widespread globally. Women are particularly affected, with one in five in Europe suffering from iron ...